EBOSY · EBOS Group Limited
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
The closing range uses available history since Dec 5, 2025; less than a full year is stored.
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EBOSY
this stock
EBOS Group Limited
|
$2.37B | — | — | — | 0.0% |
|
MCK
Mckesson Corp
|
$127.33B | +34.4% | +3.1% | 28.4 | 1.7% |
|
COR
Cencora, Inc.
|
$68.51B | +6.3% | +9.3% | 26.7 | 1.7% |
|
CAH
Cardinal Health Inc
|
$64.97B | +36.8% | +14.2% | — | 3.3% |
|
HSIC
Henry Schein Inc
|
$9.53B | +14.1% | +5.9% | 23.6 | 8.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EBOSY | -12.8% | — | — | -2.7% | -35.3% |
| SPY | -0.1% | +1.3% | +5.6% | +1.3% | +13.3% |
| vs SPY | -12.7% | — | — | -3.9% | -48.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.